Is there still a role for induction chemotherapy for head and neck cancer?

Journal of Clinical Oncology

Volumn 23, Issue 6, 2005, Pages 1059-1060

  Garden, Adam S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN DERIVATIVE;

CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; CHEMOTHERAPY; CLINICAL TRIAL; EDITORIAL; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; MICROMETASTASIS; NASOPHARYNX CANCER; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; HEAD AND NECK TUMOR; MULTIMODALITY CANCER THERAPY; NOTE; REMISSION; SQUAMOUS CELL CARCINOMA; STATISTICS;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; REMISSION INDUCTION;

EID: 14544303661     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.925     Document Type: Editorial

References (9)

1. Chua D, Ma J, Sham J, et al: Long-term survival after cisplatin-based chemotherapy and radiotherapy for nasopharyngeal carcinoma: A pooled data analysis of two phase III trials. J Clin Oncol 23:1118-1124, 2005
2. Pignon J, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group-Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955, 2000
3. The Department of Veteran Affairs Larynx Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 19921
4. Lefebvre J, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
5. Forastiere A, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
6. Shin D, Glisson B, Khuri F, et al: Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 95:322-330, 2002
7. Kies M, Haraf D, Athanasiadis I, et al: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival. J Clin Oncol 16:2715-2721, 1998
8. Johnson F, Garden A, Palmer J, et al: A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer 100:991-998, 2004
9. Betensky R, Louis D, Cairncross J: Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol 20:2495-2499, 2002